Can analysts adopt a bullish outlook for Athersys, Inc. (NASDAQ:ATHX)?

Athersys, Inc. (NASDAQ:ATHX) Logo
Investors sentiment increased to 2.1 in 2019 Q2. Its up 0.97, from 1.13 in 2019Q1. It is positive, as 6 investors sold Athersys, Inc. shares while 15 reduced holdings. 14 funds opened positions while 30 raised stakes. 32.17 million shares or 11.85% more from 28.76 million shares in 2019Q1 were reported.
Sequoia Ltd Com, Ohio-based fund reported 80,000 shares. Morgan Stanley has invested 0% in Athersys, Inc. (NASDAQ:ATHX). 45,829 were accumulated by Jane Street Group Limited Liability. Vanguard Gp reported 6.32 million shares. Aqr Ltd Liability Corp reported 13,981 shares. Bankshares Of Montreal Can has invested 0% in Athersys, Inc. (NASDAQ:ATHX). Tci Wealth invested 0% in Athersys, Inc. (NASDAQ:ATHX). Barclays Public Limited Company holds 82,545 shares. Rhumbline Advisers accumulated 156,616 shares. Royal Fincl Bank Of Canada stated it has 0% in Athersys, Inc. (NASDAQ:ATHX). Citigroup, a New York-based fund reported 39,914 shares. accumulated 0% or 81,409 shares. Deutsche Commercial Bank Ag owns 0% invested in Athersys, Inc. (NASDAQ:ATHX) for 99,944 shares. State Of Wisconsin Inv Board stated it has 154,500 shares or 0% of all its holdings. Principal Finance Group accumulated 16,020 shares or 0% of the stock.

Athersys, Inc. (NASDAQ:ATHX) Ratings Coverage

Among 3 analysts covering Athersys (NASDAQ:ATHX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Athersys has $1100 highest and $6 lowest target. $8.33’s average target is 455.33% above currents $1.5 stock price. Athersys had 4 analyst reports since March 15, 2019 according to SRatingsIntel. As per Friday, March 15, the company rating was maintained by Maxim Group. The stock has “Buy” rating by Needham on Friday, March 15. Below is a list of Athersys, Inc. (NASDAQ:ATHX) latest ratings and price target changes.

26/08/2019 Broker: Dawson James Rating: Buy New Target: $11.0000 Initiates Coverage On
19/05/2019 Broker: BidaskScore Rating: Sell Upgrade
15/03/2019 Broker: Needham Rating: Buy New Target: $6 Maintain
15/03/2019 Broker: Maxim Group Rating: Buy New Target: $8 Maintain

The stock increased 1.35% or $0.02 during the last trading session, reaching $1.5. About 671,773 shares traded or 14.14% up from the average. Athersys, Inc. (NASDAQ:ATHX) has declined 26.06% since September 13, 2018 and is downtrending. It has underperformed by 26.06% the S&P500.

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company has market cap of $229.02 million. The Company’s clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. It currently has negative earnings. The companyÂ’s lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which has completed Phase 2 study for treating patients suffering from moderate and severe ischemic stroke; that is in Phase 2 clinical study for treating patients with acute myocardial infarction; and, which is in Phase 1/2 clinical study for treating patients with acute respiratory distress syndrome, as well as completed Phase 1 clinical study for patients suffering from leukemia or various other blood-borne cancers.

More notable recent Athersys, Inc. (NASDAQ:ATHX) news were published by: Seekingalpha.com which released: “Athersys, Inc. 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” on August 08, 2019, also Globenewswire.com with their article: “Athersys Reports First Quarter 2019 Results Nasdaq:ATHX – GlobeNewswire” published on May 08, 2019, Nasdaq.com published: “Athersys (ATHX) Q4 Earnings: What’s in Store for the Stock? – Nasdaq” on March 07, 2019. More interesting news about Athersys, Inc. (NASDAQ:ATHX) were released by: Seekingalpha.com and their article: “Seaport sees 25% upside in Canopy Growth in premarket analyst action – Seeking Alpha” published on August 26, 2019 as well as Finance.Yahoo.com‘s news article titled: “Do Institutions Own Shares In Athersys, Inc. (NASDAQ:ATHX)? – Yahoo Finance” with publication date: July 31, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.